Rayonier Advanced Materials Reports Resilient Q3 2025 Results, Progresses Growth Strategy

Rayonier Advanced Materials (RYAM) reported a resilient third quarter of 2025 with net sales of $353 million, a $48 million decline from last year, and a reduced loss from continuing operations of $4 million. The company’s core Cellulose Specialties business approached normalized levels with improving demand and operational efficiency despite industry headwinds like tariff impacts and labor strikes. Adjusted EBITDA was $42 million, reflecting ongoing cost discipline and favorable energy cost benefits. RYAM remains focused on its long-term growth roadmap, targeting over $300 million in annual EBITDA by the end of 2027, driven by price actions, efficiency gains, and the expansion of its Biomaterials division. Operational adjustments and strategic initiatives position RYAM to navigate market challenges and capitalize on sustainable growth opportunities ahead.